This, on one hand, implicates that the network, once trimed to capture breast cancer heterogeneity, is shifted towards ER-driven and, on the other hand, suggests the critical roles played by APP in mediating carcinogenesis and subtype differentiation. Here, ESR1 is linked to breast cancer.